Semnur Pharmaceuticals, Inc. (SMNR)
0.55
0.00 (0.00%)
USD |
OTCM |
Aug 31, 16:00
Semnur Pharmaceuticals Debt to Equity Ratio : -0.7768 for June 30, 2026
Debt to Equity Ratio Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Debt to Equity Ratio Data
| Date | Value |
|---|---|
| June 30, 2026 | -0.7768 |
| March 31, 2026 | -0.7771 |
| December 31, 2025 | -0.7443 |
| September 30, 2025 | -0.6724 |
| June 30, 2025 | -0.2821 |
| March 31, 2025 | -1.834 |
| December 31, 2024 | -1.155 |
| September 30, 2024 | -4.719 |
| June 30, 2024 | 0.056 |
| Date | Value |
|---|---|
| March 31, 2024 | 0.0504 |
| December 31, 2023 | 0.0431 |
| September 30, 2023 | 0.016 |
| June 30, 2023 | 0.0051 |
| March 31, 2023 | 0.00 |
| December 31, 2022 | 0.00 |
| September 30, 2022 | 0.00 |
| June 30, 2022 | 0.00 |
| March 31, 2022 | 5.839 |
Debt to Equity Ratio Definition
The debt to equity ratio measures the (Long Term Debt + Current Portion of Long Term Debt) / Total Shareholders' Equity. This metric is useful when analyzing the health of a company's balance sheet.
Debt to Equity Ratio Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Debt to Equity Ratio Benchmarks
| Scilex Holding Co. | -0.3437 |
| ANI Pharmaceuticals, Inc. | 1.022 |
| Corcept Therapeutics, Inc. | 0.0133 |
| Veru, Inc. | 0.0945 |
| Johnson & Johnson | 0.5771 |
Debt to Equity Ratio Related Metrics
| Total Assets (Quarterly) | 1.943M |
| Total Liabilities (Quarterly) | 31.62M |
| Shareholders Equity (Quarterly) | -29.67M |
| Current Ratio | 0.1118 |
| Net Debt Paydown Yield | -3.50% |